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EXPLANATION OF THESIS FORMAT 
This dissertation consists of an introduction, a literature review, 
two separate manuscripts, a general conclusion, references and acknowl­
edgements. The Ph.D. candidate, Melissa Anne Lum, is the senior author 
and principal investigator for each of the manuscripts. 
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INTRODUCTION 
Bovine herpesvirus-1 (BHV-1) is the most commonly diagnosed viral 
etiologic agent in bovine respiratory disease and bovine abortion (40, 
42,77). Despite continued use of BHV-1 vaccines, economic losses remain 
severe. The efficacy of both attenuated and killed BHV-1 vaccines has 
been reviewed (25,51,73). In general, present BHV-1 vaccines are able 
to protect against disease, tut none is effective in preventing infection 
with virulent challenge virus (51,84). Disease control is hampered by 
the ability of BHV-1 (wild-type or vaccine origin) to establish latent 
infections. In some instances, virus is shed sporadically for many years 
and persists through infection of new animals (91). 
Nonionic detergents are thought to remove immunologically important 
herpesvirus glycoproteins from the virion envelope and infected cell 
extracts (65,96,98). A detergent-solubilized, BHV-1 infected cell extract, 
used as a subunit vaccine in calves, was found to be immunogenic and 
efficacious when administered with adjuvant. This virus-free extract 
induced high serum neutralizing antibody titers in all vaccinated animals; 
vaccinates challenged with virulent BHV-1 appeared to be protected from 
infection as well as disease (51). Detergent treatment of the BHV-1 virion 
removed thirteen polypeptides which were thought to be associated with the 
virion envelope (3). A detergent-soluble, virus specified glycoprotein, 
GVP 11 (71K dalton) was detected on the surface of BHV-1 infected cells 
and identified as a potential immunogen. Monoclonal antibody prepared 
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against GVP 11 was able to participate in antibody-complement mediated 
immunocytolysis of infected cells (56). 
The objectives in this study were to identify and characterize 
detergent-soluble, BHV-1 specified proteins involved in inducing serum 
neutralizing antibody. 
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LITERATURE REVIEW 
Bovine herpesvirus-1 (BHV-1), commonly known as the infectious 
bovine rhinotracheitis virus, causes a variety of disease syndromes in 
cattle. Infection with BHV-1 is associated primarily with respiratory 
disease, but reproductive, enteric, ocular, central nervous system, 
neonatal and dermal infections also may occur. Combined disease syndromes 
and persistent infections have,been reported (25,40). 
Herpes simplex virus-1 proteins 
Because herpes simplex viruses were the first of the herpesviruses 
to be analyzed extensively, their study has served as a model for the 
study of BHV-1. Discussion of non-BHV-1 herpesviruses, then, will be 
limited to herpes simplex virus-1 (HSV-1). 
Forty-nine virus specified polypeptides were identified, by sodium 
dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE), from HSV-1 
infected cells (36). Thirty-three polypeptides were present in the HSV-1 
virion, at least twelve of these were glycosylated (31). 
Immunogenic subunits 
Herpesviruses are composed, basically, of a nucleocapsid and an 
envelope (57). Studies comparing immune responses to nucleocapsid versus 
envelope antigens indicate that the immunologically important HSV-1 
antigens are glycoproteins located in the virion envelope (5,48,98). 
Rabbits immunized with HSV-1 envelope antigens developed high serum 
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neutralizing (6,48,108) and complement fixing (5,48) antibody titers, 
as well as a cellular immune response (5,6); rabbits were protected from 
lethal challenge with HSV-1 (108). Human convalescent sera also demon­
strated cellular (41) and humoral (53) immune responses against envelope 
antigens. 
Herpes simplex virus specified glycoproteins become incorporated 
into host cell membranes (27,32,64,78,95). These proteins demonstrate 
protective activity and correspond antigenically (16,19,39,75,78,80, 
82,83,87,94,98) and biochemically (95) to those present in the virion 
envelope. Crude, detergent-solubilized extracts from HSV-1 infected 
cells induce high serum neutralizing antibody titers in immunized rabbits 
(98), guinea pigs, hamsters and mice (44); immunized mice were protected 
from lethal challenge with HSV-1 (43,65). 
HSV-1 glycoproteins 
Detergent-solubilized, ^ C^-glucosamine-labeled, HSV-1 virions and 
infected cell extracts were used to form crossed immunoelectrophoretic 
(CIE) patterns (16,96,98,100,102). Three distinct viral glycoprotein 
antigens (Ags), Ag 6, Ag 8 and Ag 11 were identified consistently from 
14 these patterns (50,63,64,97,100). Polypeptide profiles of C-glucosamine-
labeled HSV-1 virions and infected cell membrane antigens were formed using 
SDS-PAGE (31,32,36,95). The HSV-1 infected cell membrane glycopeptides 
(ICP), TCP 7, ICP 8 and ICP 18 were electrophoretically similar to the 
major virion glycopeptides (VPs), VP7, VP8, and VP 18, respectively (32, 
94). The major virion glycopeptide, VP8.5, was resolved using a different 
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crosslinker in SDS-PAGE (31). The CIE Ags 6, 8 and 11 formed poly­
peptide patterns identical to those formed fay the SDS-PAGE VPs 8, 18 
and 7+8.5, respectively (62). An 80K glycopeptide, with affinity for 
the immunoglobulin region, was isolated from HSV-1 infected cell 
extracts and was found to be distinct from the HSV-1 glycopeptides 
mentioned above (1). 
Five HSV-1 glycoproteins were recognized and designated gA, gB, 
gC, gD and gE (See Table 1) with molecular weights of 119K (94), 126K 
(94), 129K (31), 59K (11), and 8OK (1) dalton, respectively. The gly­
coproteins gA, gB, gC and gD correspond to the virion polypeptides 8.5, 
7, 8 and 18, respectively (94). Glycoprotein gE corresponds to the 
80K F^  binding glycopeptide (1,58). Lactoperoxidase-catalyzed radio-
iodination experiments indicated that each of these glycoproteins was 
present on the surfaces of the HSV-1 virion and HSV-1 infected cells 
(1,27,58,59). Recent studies indicate that gA is a precursor to gB 
and is not incorporated into virions (20,29,94). 
To aid in further characterization, monospecific antibody was prepared 
against each of the HSV-1 glycoproteins. A mixture of gA and gB was 
prepared from infected cell extracts and separated by SDS-hydroxylapatite 
chromatography; the purified antigens were used to produce monospecific 
antibody in rabbits (20). Anti-gC antibody was produced by adsorbing 
polyspecific sera with an HSV-1 mutant lacking gC (94), or by immunizing 
rabbits with gC isolated from preparative CIE (101) or SDS-PAGE (16,75,76) 
gels. Anti-gD antibody was prepared by immunizing rabbits with chromato-
graphically purified gD (11) , or with gD isolated from preparative 
Table 1. Major HSV-1 glycoproteins 
Molecular 
Glyco- Weight Early/Late 
proteins (K daltons) Synthesis Location Function 
gA 119 late Infected cell precursor to gB 
membranes 
gB 126 late virion envelope important for 
infected cell infectivity 
. membranes promotes 
membrane fusion 
for penetration 
gC 129 late virion envelope polykaryocyte 
infected cell inhibition 
membranes 
gD 59 late virion envelope fusion (?) 
infected cell 
membranes 
gE 80 late virion envelope F receptor 
infected cell 
membranes 
VN, virus neutralization; ADCC, antibody dependent cell mediated 
cytotoxicity; AbC', antibody-complement mediated cytolysis; VN(C'), 
complement mediated virus neutralization. 
b 
unique long segment; U^ , unique short segment. 
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Gene Map 
Precursor Immunological Location 
Forms Properties ® segment^  /map units References 
pgA VN U 20,37,62,85,94 
ADCC 
AbC 0.30-0.42 
pgA VN U 20,27,37,52,59, 
gA ADCC 62,85,86,94 
pgB AbC 0.30-0.42 
pgC VN U 12,27,31,37,52, 
ADCC 59,62,85 
AbC' 0.53-0.645 
pgD VN U 11,26,27,37,46, 
ADCC  ^ 54,59,62,69 
AbC' 0.911-0.924 
pE VN(C') 1,37,46,68,69 
gEi 0.924-0.951 
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CIE (102), SDS-PAGE (75,76) or Ouchterlony (103) gels. Antibody against 
gE was prepared by immunizing rabbits with gE purified from affinity 
columns (1,68). 
Monospecific antibody preparations against glycoproteins gB, gC 
and gD neutralized infectious virus and were able to participate in 
antibody-complement mediated immunocytolysis as well as antibody-dependent 
cell mediated cytolysis (62). Neutralization of infectious virus by 
anti-gE antibody required complement-(68). Mice passively immunized 
with monoclonal antibody directed against glycoprotein gD or gC were pro­
tected against acute neurological disease induced by HSV-1 (18). Purified 
glycoprotein gD induced high titers of neutralizing antibody in mice (24) , 
and rabbits immunized with a cloned glycoprotein gD/3-galactosidase fusion 
protein produced neutralizing antibody to HSV-1 (104). 
Antigenic sites 
Monoclonal antibody directed against an HSV-1 glycoprotein gC 
epitope was used to select neutralization resistant HSV-1 mutants. Two 
antigenic sites on the glycoprotein gC were discovered by comparing the 
mutants' patterns of resistance to neutralization by a panel of anti-gC 
monoclonal antibodies (34). 
Seven separate HSV-1 glycoprotein gD determinants were demonstrated 
by comparing reactions of seven groups of monoclonal antibodies to gly­
coprotein gD in radioimmune precipitation and neutralization assays. 
Glycoprotein gD, bound to the same panel of monoclonal antibodies was 
digested with Staphylococcus V8 protease. Digest patterns revealed two 
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major antigenically active gD fragments that remained bound to the anti­
body; a 38K fragment contained three epitopes and a 12K fragment contained 
one epitope. Tryptic peptide analysis revealed that the 12K fragment 
was a subset of the 38K fragment. Two groups of monoclonal antibodies 
recognized the denatured form of gD, suggesting that at least two epitopes 
were sequential (not conformational) in nature (22). The same panel of 
monoclonal antibodies was used to study the ^  vitro translation and 
processing of glycoprotein gD. One group of antibodies recognized a gD 
epitope located on the outside of the infected cell membrane and demon­
strated virus neutralizing activity. A different group of antibodies 
recognized an epitope located on the inside of the host cell membrane 
and did not demonstrate virus neutralizing activity (54). 
Glycoprotein precursors 
The synthesis and processing of the major HSV-1 glycoproteins gB, 
gC, gD and gE involve the production of partially glycosylated intermediate 
forms that demonstrate the same antigenic activity as the fully glyco­
sylated, mature forms (38,58,61,68,94). Monospecific antisera and mono­
clonal antibody prepared against mature glycoproteins also react with 
precursor forms (12,20,61,68,71,94,106). 
The HSV-1 glycoprotein gA was found to be related antigenically to 
gB (20,71). Pulse chase and immunoprecipitation SDS-PAGE studies demon­
strated that gA was a precursor to gB (20). The precursor polypeptide 
pgA was synthesized first, followed by gA, pgB and finally gB (20). The 
fully glycosylated gB molecule was found to exist as a dimer (86) . The 
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unglycosylated form of gB, not normally isolated from infected cell 
extracts, was produced when HSV-1 was grown in the presence of tunicamycin 
(61). Immunoblot studies using the unglycosylated form of gB indicate 
that the immunologic specificity of gB resides in the protein rather than 
the carbohydrate; glycosylation appears to be necessary for intracellular 
transport to and expression on the surfaces of infected cells (61)• 
Monospecific antibody to the HSV-1 glycoprotein gC immunoprecipitates 
gC and its precursors, nonglycosylated gC (85K) and pgC (llOK) from in­
fected cell extracts (12,70,72,106). The precursor molecules formed 
tryptic peptide patterns identical to that formed by gC (11,12,21,72). 
In two dimensional electrophoresis, gC exhibited greater negative charge, 
molecular weight and heterogeneity than pgC (12). These data suggest 
that gC maturation does not involve proteolytic cleavage (94), but results 
solely from the addition of carbohydrate to the underglycosylated forms 
(12). This hypothesis was supported by studies monitoring the synthesis 
of gC in the presence of tunicamycin and the sensitivity of both pgC and 
gC to endoglycosylase (72) and mild alkaline hydrolysis (105,106). Results 
indicated that high mannose oligosaccharides were added to the growing gC 
polypeptide to form pgC. The N-linked, high mannose oligosaccharides were 
processed to complex oligosaccharides concomitantly with the addition of 
O-linked oligosaccharides to pgC to form the fully glycosylated gC (66,88). 
The biosynthesis of HSV-1 glycoprotein gD also is characterized by 
multiple stages of poat-translational modification (2). Methionine and 
arginine tryptic peptide maps of gD and its precursor pgD were shown to 
be identical, indicating that the maturation process did not involve 
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major alterations of basic polypeptide structure (64,94). Experiments 
with tunicamycin indicate that an oligomannosyl residue is added to a 
50K core polypeptide before it is released from the polysome (21,46,72). 
The precursor pgD acquires sialic acid, which is added to the oligo­
mannosyl residue, and carbohydrate to form the fully glycosylated 59K 
molecule, gD (11,13,31,23). As with gB, immunoblot studies indicate 
that the immunologic specificity of gD resides in the unglycosylated 
core protein (61). 
Three electrophoretically distinct forms of the HSV-1 glycoprotein 
gE—pE, gE^  and gE^ —were identified in HSV-1 infected cell extracts 
(1,68). Proteolytic digestion and pulse chase studies indicate that they 
may represent post-translationally modified forms of a single translation 
product. The precursor molecule, pE, is thought to be processed to form 
gE^ , which in turn is processed to form the fully glycosylated molecule 
gEg (1). 
Biological function of HSV-1 glycoproteins 
Herpes simplex virus-1 glycoproteins gB, gC, gD and gE are the major 
virus specified proteins incçrporated into virion envelopes and plasma 
membranes of infected cells (1,94). All four glycoproteins serve as 
immunological targets for the host immune system (62,68). In HSV-1 
infected cells, glycoproteins gB, gC and gD participate as targets in 
antibody-dependent, cell mediated cytolysis or in complement-dependent 
cytolysis (62). These same glycoproteins also may serve as target antigens 
for virus specified cytotoxic T-lymphocytes (7,45,89) and natural killer 
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cells (8). Anti-gB, anti-gC and anti-gD sera neutralize virus in the 
absence of complement (11,16,75,92,102), whereas virus neutralization 
by anti-gE sera requires complement (68). All four HSV-1 glycoproteins 
possess type common and type specific antigenic determinants (10,11,22, 
23,28,30,34,60,62,68,75,102,109,110,111). 
Studies with HSV-1 glycoprotein gB temperature sensitive mutants 
suggest that gB is required for virus infectivity. Glycoprotein gB is 
thought to promote fusion between the virion envelope and host cell 
membrane for nucleocapsid entry into the host cell (4,20,49,52,67,86,90). 
Herpes simplex virus-1 mutant recombinants were used to map nucleotide 
sequences which specify determinants involved in syncytium formation, 
rate of virus entry and production of gB to the region of the genome 
coding for glycoprotein gB (17). 
In some instances, HSV-1 mutants defective in their ability to pro­
duce glycoprotein gC induce polykaryocyte formation in infected cells 
(33,35,52,79). Glycoprotein gC appears to suppress virus induced cell 
fusion (52,81) by modifying the fusion promoting function of glycoprotein 
gB (17,85). 
Little is known about the biological function of HSV-1 glycoprotein 
gD. Because of its ability to stimulate high titers of type common virus 
neutralizing antibody, it is thought to play an important role in the 
initial stages of virus infection (11,12,13,22,94). Anti-gD antibodies 
have been shown to block virus induced cell fusion (26). 
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Herpes simplex virus-1 glycoprotein gE has been shown to function 
as a receptor for the region of rabbit IgG (1,68). It has been 
hypothesized (1) that the binding of IgG to gE receptors could 1) inter­
fere with the immune cytolysis of both virions and infected cells (14,47), 
2) influence expression of viral gene products in infected cells, perhaps 
leading to the establishment of latency or malignant transformation (15, 
47,107), 3) reduce the yield of infectious progeny from HSV-1 infected 
cells (15), 4) influence virus induced cell fusion (1) and/or 5) contrib­
ute to immune complex deposition in vascular tissue after certain HSV-1 
infections (9). 
Bovine herpesvirus-1 proteins 
Forty-eight virus specified polypeptides were identified by SDS-PAGE 
analysis of BHV-1 infected cells (55). Thirty-three polypeptides were 
found to be present in the virion (3,55) and eleven of these were gly­
cosylated (55). 
Like HSV-1, the immunologically important BHV-1 antigens are thought 
to be glycoproteins located in the virion envelope and infected cell 
.membranes. Nonionic detergents have been used to remove quantitatively 
HSV-1 glycoproteins, with serum neutralizing activity, from virions and 
infected cells (5,74,93,96,98,99). Nonidet P-40 or Triton X-100 solu-
bilized BHV-1 infected cell extracts protected vaccinated cattle from 
disease following challenge with virulent virus (51). 
Triton X-100 quantitatively removed two major BHV-1 polypeptides, 
vp8 (90K) and vpl3 (73K), of potential immunologic importance from the 
14 
virion envelope (3). These two polypeptides corresponded to two 
glycosylated BHV-1 structural polypeptides, GVP 9 (80K) and GVP 11 (71K), 
reported in a separate study (3,55). Monoclonal antibody prepared against 
GVP 11 was used 1) to detect the presence of GVP 11 on the surfaces of 
infected cells, and 2) to demonstrate the ability of GVP 11 to participate 
in antibody-complement mediated immunocytolysis of infected cells (56). 
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PART I. ELECTROPHORETIC PROTEIN TRANSFER APPLIED TO IMMUNOELECTROPHORESIS 
This manuscript has been published in the Journal of Immunological Methods 
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ELECTROPHORETIC PROTEIN TRANSFER APPLIED TO IMMUNOELECTROPHORESIS 
M. A. Lum 
D. E. Reed 
From the Veterinary Medical Research Institute, Iowa State University, 
Ames, Iowa 50011, 
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SUMMARY 
A method for electrophoretic transfer of a crossed immunoelectro-
phoretic (CIE) pattern from an agarose gel onto a nitrocellulose sheet 
is described. The CIE pattern to be transferred was formed using 
Nonidet P-40 solubilized, bovine herpesvirus-1 (BHV-1) antigens 
and bovine hyperimmune serum. An autoradiogram of a CIE pattern, formed 
35 
using S-methionine-labeled, NP-40 solubilized, BHV-1 induced antigens 
and bovine hyperimmune serum, was used as a control pattern. Both antigen 
and antibody were transferred to the nitrocellulose sheet. This was 
demonstrated by the ability of transferred antigen to react with specific 
125 
antibody (detected by the addition of I-labeled anti-species antibody) 
35 
and transferred antibody to react with both S-methionine-labeled antigen 
125 
and I-labeled protein A. This method has application for determining 
the specificity of monospecific sera for individual arcs in CIE patterns. 
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INTRODUCTION 
Crossed immunoelectrophoresis has been used to establish undenatured 
antigen reference patterns from crude, detergent solubilized antigen 
mixtures (5). The specificities of sera directed against one or more 
antigens within the pattern most commonly are tested by intermediate gel 
crossed immunoelectrophoresis. The results from this technique are difficult 
to interpret when several antigens in the reference pattern coelectrophorese 
and immunoprecipitate in close proximity. A method for In situ identifi­
cation of serum-specific antigens in a crossed immunoelectrophoresis 
reference pattern has been described (2). This method requires the labeling 
125 
of each serum sample with I, and is impractical when many samples are to 
be tested. The Western blot transfer method has been applied to sodium 
dodecylsulfate polyacrylamide gel electrophoresis polypeptide patterns (4). 
Transfer of polypeptide patterns to a nitrocellulose sheet allows for in situ 
identification of polypeptides that react with test sera. The purpose of , 
the present study was to adapt the Western blot method for in situ identifi­
cation of serum-specific, undenatured antigens in a crossed immunoelectro-
phoretic pattern. 
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• MATERIALS AND METHODS 
Preparation of Reference Antigen 
2 
Monolayers (850 cm roller bottles) of Georgia bovine kidney cells 
(Dr. R. F. Solarzano, University of Missouri, Columbia, MO) were infected 
with bovine herpesvirus-1 (BHV-1) at a multiplicity of 0.1-1 plaque-
forming units (PFU)/cell. At 100% cytopathic effect (approximately 48 
hours), infected cells were harvested and solubilized in 0.025 M Tris-
Tricine buffer (4.3 g/1 THAM, 9.8 g/1 Tricine, 0.11 g/1 calcium lactate 
and 0.2 g/1 sodium azide), containing 1% (v/v) Nonidet P-40 at pH 8.6. 
The solubilized material was clarified by centrifugation at 100,000 x g 
for 1 hour, at 4°C, and the supernatant fluid was designated 'crude antigen 
extract' (CAE). Radiolabeled CAE was prepared in the same manner with the 
35 
addition of L- S-methionine (500 yCi/roller bottle; 1015.7 Ci/mmol) to 
cell culture media 6 hours postinfection; cells were infected at a multi­
plicity of 5-10 PFU/cell and harvested at 100% cytopathic effect (approx­
imately 24 hours). 
Preparation of Reference Antibodies 
Hyperimmune serum was prepared in calves that were given 3 weekly, 
intramuscular inoculations with CAE emulsified in Freund's incomplete 
adjuvant. Globulin was prepared by ammonium sulfate precipitation according 
to Campbell et al. (1), with the final resuspension in 0.025 M Tris-Tricine 
buffer (TT buffer, pH 8.6) containing 0.15 M NaCl. 
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Establishing a Crossed Immunoelectrophoresis Reference Pattern 
The procedures for crossed immunoelectrophoresis were essentially 
the same as those used by Vestergaard (5). One percent (BioRad, standard 
low m^ ) agarose was prepared in TT buffer containing 1% Triton X-100 and 
1% polyethylene glycol 6000 (TTT buffer, pH 8.6). The TTT buffer (pH 8.6) 
also was present in electrophoresis chambers. First dimension electro­
phoresis was performed on a 20 yl sample of CAE (approximately 0.1 mg of 
total protein) at 10 V/cm for 90 min, at 10°C. In the second dimension, 
the separated antigens were electrophoresed into agarose containing 5% 
reference antibody, using 1.5 V/cm for 18-24 hours at 10°C. When desired, 
Coomassie brilliant blue R250 stain was used to visualize precipitates. 
Electrophoretic Transfer of the Reference Pattern to Nitrocellulose 
After immunoelectrophoresis, the gel was removed from the plastic 
plate and electrophoretic blot transfer was performed according to Towbin, 
et al. (4), with the following modifications: (1) single sheets of filter 
paper were placed on the cathodic side of the gel and on the anodic side 
of the nitrocellulose; (2) Tris-Tricine buffer, pH 11, was used as the 
transfer buffer; and (3) transfer was performed for a total of 3 hours, 
at 0.5 A for the first 30 min, 1.0 A for 2 hours and 1.5 A for the final 
30 min. When desired, Coomassie brilliant blue R250 was used to detect 
post-transfer precipitation patterns in the gel and on the nitrocellulose 
sheet. 
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Preparation of Test Antibodies 
Test antigens, against which test antibodies were formed, were prepared 
by line immunoelectrophoresis (3). The antigen trough contained CAE and 
the 1% agarose contained 20-30% of lapine serum directed against one or more 
antigens present in the CAE mixture. Individual precipitin lines were 
harvested from the gel, emulsified with Freund's incomplete adjuvant and 
used to vaccinate young adult rabbits; rabbits were given 3 weekly, intra­
muscular inoculations. 
Reaction of the Nitrocellulose-Transferred Reference Pattern with Test 
Antibodies 
After electrophoretic transfer, the nitrocellulose sheets were treated 
as follows: 
Step 1. One hour wash in 50 ml of 0.01 M Tris-saline buffer, containing 
5% bovine serum albumin (TS-BSA buffer, pH 8.6). 
Step 2. Two hour incubation with 0.5 ml of test antibody in 50 ml 
of fresh TS-BSA buffer. 
Step 3. One hour wash in 50 ml of 0.01 M Tris-saline buffer (TS 
buffer, pH 8.6). 
Step 4. Two 30 min washes in 50 ml of 0.01 M Tris-saline buffer, 
containing 0.05% Nonidet P-40. 
Step 5. One hour wash in 50 ml of TS buffer, pK 8.6. 
125 Step 6. One hour incubation with 6 yCi I-labeled goat anti-rabbit 
IgG (6.95 yCi/vg) in 50 ml of TS-BSA, pH 8.6. 
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Step 7. Repeat steps 3 through 5. 
Controls were run by substituting other reagents for test antibody in 
125 
step 2 and I-labeled goat anti-rabbit IgG in step 6 as follows: 
35 (1) Antibody transfer was detected by the addition of S-labeled 
CAE at step 2 and only TS-BSA at step 6, or, only TS-BSA at step 2 and 
12S 
7 yCi I-labeled protein A (9.2 yCi/yg) at step 6. 
(2) Antigen transfer was detected by the addition of rabbit anti-CAE 
125 
antibody at step 2 and I-labeled goat anti-rabbit IgG at step 6. 
125 (3) Nonspecific I-labeled goat anti-rabbit IgG reactions were 
detected by the addition of reference antibody, normal rabbit antibody or 
125 
no antibody at step 2 and I-labeled goat anti-rabbit IgG at step 6. 
Autoradiography 
Data were analyzed by direct autoradiography at -70°C, using Kodak 
XAR-5 film and an intensifying screen. 
23 
RESULTS 
The CIE reference pattern (Fig. 1) was transferred intact to the 
nitrocellulose (Fig. 2). Coomassie brilliant blue staining of the agarose 
gel after transfer revealed no trace of the reference pattern. Both antigen 
and antibody were transferred to the nitrocellulose; transferred antigens 
were detected by reaction with rabbit anti-CAE antibodies (Fig. 3), and 
125 
transferred antibodies were detected by reaction with 1-labeled protein A 
35 (Fig. 4) or S-labeled CAE (Fig. 5). An autoradiograph of a reference 
35 pattern formed using S-labeled CAE (Fig. 6) did not reveal any antigens 
additional to those found in the Coomassie brilliant blue stained reference 
125 
pattern. Nonspecific reactions of the I-labeled goat anti-rabbit IgG 
with the transferred reference pattern were not apparent. Test antibody 
reactions with specific antigens within the transferred CIE pattern are 
shown in Figs. 7, 8 and 9. 
Figure 1 Coomassie brilliant blue stain of the agarose reference 
pattern. 
Figure 2 Coomassie brilliant blue stain of the nitrocellulose 
sheet after transfer. 
Figure 3 Autoradiograph of the transferred pattern after reaction 
125 
with rabbit anti-CAE, followed by I-labeled goat 
anti-rabbit IgG. 
Figure 4 Autoradiograph of the transferred pattern after reaction 
125 
with I-labeled protein A. 
Figure 5 Autoradiograph of the transferred pattern after reaction 
35 
with S-labeled CAE. 
Figure 6 Autoradiograph of the agarose reference pattern formed 
35 
using S-labeled CAE. 

Figure 7 Autoradiograph of the transferred pattern after reaction 
with test antibody directed against a higher antigen arc, 
125 followed by I-labeled goat anti-rabbit IgG. 
Figure 8 Autoradiograph of the transferred pattern after reaction 
with test antibody directed against several lower antigen 
125 
arcs, followed by I-labeled goat anti-rabbit IgG. 
Figure 9 Autoradiograph of the transferred pattern after reaction 
with test antibody directed against higher and lower antigen 
125 
arcs followed by I-labeled goat anti-rabbit IgG. 
27 
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DISCUSSION 
The electrophoretic transfer of BHV-1 CIE patterns to nitrocellulose 
was successful. The dissociation of antigen-antibody complexes at high 
pH probably facilitated the transfer of the protein arcs out of the agarose 
and onto the nitrocellulose. The immunologic reactivities of antigen and 
antibody appeared to survive the transfer procedure, and the ability of test 
antibodies to react with specific antigen arcs in the transferred pattern 
was demonstrated. Preliminary data (not shown) for transfer at pH 6.8 and 
pH 3-3.5 demonstrated incomplete transfer of patterns at both pH levels 
and nonreactivity of the transferred pattern with protein A at the lower pH. 
Potential applications for this method include (1) determining the 
specificity and confirming the purity of monospecific sera, and (2) identi­
fying receptor-ligand functions among antigens. This transfer method con­
ceivably could be adapted to all types of immunoelectrophoretic patterns. 
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SUMMARY 
Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus) 
infected cell antigens were solubilized with Nonidet-P-40. The crude 
antigen extract was separated by reaction with bovine hyperimmune serum 
in line immunoelectrophoresis; individual immunoprecipitates were used 
to immunize rabbits. Rabbit sera possessing serum neutralizing activity 
were analyzed by reaction with crude antigen extract in immunoprecipitation 
sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) and 
Western blot. A 77-81K dalton glycopeptide and an 82-92K dalton glyco-
peptide appeared to be involved, separately, in inducing serum neutralizing 
antibody. Two glycosylated polypeptides (69-75K and 108-115K dalton) 
always co-precipitated and also induced serum neutralizing antibody. 
34 
INTRODUCTION 
Bovine herpesvirus-1 (BHV-1), commonly known as the infectious 
bovine rhinotracheitis virus, is a cause of rhinotracheitis, conjunc­
tivitis, vulvovaginitis and abortion in cattle (4) and a cause of 
alimentary and systemic infections in newborn calves (9.). 
Bovine herpesvirus-1 specific polypeptides have been identified 
using sodium dodecylsulfate polyacrylamide gel electrophoresis. Thirty-
three polypeptides were found to be structural (1,7); eleven of these were 
glycosylated (7). Fifteen nonstructural viral polypeptides additionally 
were identified from infected cell extracts (7). An envelope glycopeptide, 
GVP 11 (71.5K dalton), was reported to induce antibody participating in 
antibo9y-complement mediated immunocytolysis of infected cells (8). 
The purpose of the present study was to identify and characterize 
BHV-1 antigens involved in inducing a serum neutralizing antibody response 
in rabbits. 
35 
MATERIALS AND METHODS 
Reference Reagents 
2 Monolayers (850 cm roller bottles) of Georgia bovine kidney cells 
(Dr. R. F. Solarzano, University of Missouri, Columbia, MO) were infected 
with BHV-1 (vaccine strain from Burroughs Wellcome Company, Kansas City, 
MO), at a multiplicity of 0.1 to 1 plaque-forming unit (PFU)/cell. At 
100% cytopathic effect, infected cells were harvested and solubilized in 
0.025 M Tris-Tricine buffer, containing 1% (v/v) Nonidet P-40, at pH 8.6 
(TTNP-40 buffer). The solubilized material was stirred for 1 hour at 
4°C, sonicated for 3-20 second bursts at 100 watts, and clarified by 
centrifugation at 100,000 X g for 1 hour at 4°C. The supernate was 
designated crude antigen extract (CAE). Radiolabeled CAE was prepared in 
the same manner, with some modifications. Cells were infected at a 
35 
multiplicity of 10 PFU/cell and S-L-methionine (500 yCi/roller bottle; 
400 Ci/mmol specific activity) or ^ C^-D-glucosamine (13 yCi/roller bottle; 
60 mCi/mmol specific activity) was added to cell culture media 6 hours 
post-infection. Crude antigen extract control (CAE control) was prepared 
from uninfected Georgia bovine cells in an identical manner. 
Hyperimmune serum was prepared from a calf that was inoculated with 
CAE emulsified in Freund's incomplete adjuvant. The calf was given 6 
inoculations (3.5 mg CAE/dose) within a 12 month period. The serum was 
ammonium sulfate precipitated according to Campbell et al. (2), with the 
final resuspension in 0.025 M Tris-Tricine buffer containing 0.15 M NaCl; 
globulin was designated "reference antibody". 
36 
Monospecific Rabbit Sera 
Crossed inmunoelectrophoresis was performed as reported previously 
(6); the sample well contained 20 vil CAE (0.14 mg) and the 1% agarose 
gel contained 5% reference antibody. Groups of antigen arcs that immuno-
precipitated in close proximity were cut from the gel and each group 
was emulsified in Freund's incomplete adjuvant and used to immunize a calf. 
The calf sera were ammonium sulfate precipitated as described above. 
Rabbit anti-CAE serum was prepared from a rabbit given 3 weekly, intra­
muscular inoculations of CAE (3.5 mg/dose) emulsified in Freund's incomplete 
adjuvant. The rabbit serum was ammonium sulfate precipitated. 
Line Immunoelectrophoresis was performed according to Kr^ ll (5). The 
antigen trough contained 0.5 ml (3.5 mg) of CAE and the 1% agarose gel con­
tained 20% rabbit anti-CAE or calf antibody. Individual precipitin lines 
were cut from the gels, emulsified with Freund's incomplete adjuvant and 
used to vaccinate young adult rabbits; rabbits were given 3 weekly, intra­
muscular inoculations. The rabbit sera were ammonium sulfate precipitated 
as described above. The resulting globulins were incorporated at 20% into 
a 1% agarose gel and reacted with CAE (3.5 mg) in line Immunoelectro­
phoresis. Individual immunoprecipitates were cut from the gel and used 
to immunize rabbits. This process was repeated until monospecific sera 
(sera that immunoprecipitated a single line) were obtained; seventeen 
rabbits and 5 calves were involved in the production of these sera. For 
use in itnmunoprecipitation SDS-PAGE and Western blot, monospecific rabbit 
sera were ammonium sulfate precipitated. 
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Serum Neutralization 
The plaque-reduction serum neutralization (SN) test was used to 
determine rabbit anti-BHV-1 serum titers. Two-fold serum dilutions 
(0.3 ml) were mixed with equal amounts of MEM containing approximately 
300 plaque-forming units of BHV-1. The virus/serum mixtures were incubated 
for 1 hour at 37°C and 0.2 ml of these mixtures were inoculated onto mono­
layers of Georgia bovine kidney cells in 22 mm, 12 well tissue culture 
plates. Cultures were incubated at 37°C for 1 hour. Inocula were removed 
and monolayers were washed, then overlain with 1% agarose containing MEM, 
1% diethylaminoethane dextran, 2% fetal bovine serum and antibiotics. 
Cultures were incubated at 37°C for 48 hours before fixing and staining. 
Serum neutralizing antibody titers were expressed as the reciprocal of 
the highest serum dilution reducing the plaque count by at least 50%. 
Immunoprecipitation SDS-PAGE (IP-PAGE) 
Fifty ul of CAE was incubated with 100 yl of reference antibody or 
monospecific rabbit globulin for 4 hours at 4°C. If reference antibody 
was used, 10 yl of rabbit anti-bovine IgG (Cappel Laboratories, 
Cochranville, PA) was added and the mixture was incubated for an additional 
4 hours at 4°C. One hundred yl (0.01 mg) of Protein A Sepharose CL4B 
(Sigma Chemical Company, St. Louis, MO) was then added and the resulting 
mixture was stirred every 15 minutes for 1 hour at room temperature. 
Sepharose beads were pelleted by centrifuging for 5 minutes at 13,000 X g, 
and washed 3 times with TTNP-40 buffer. After the final wash, the supernate 
38 a 
was removed and the beads were resuspended in 50 yl of dissolving buffer 
(0.2 M Tris (pH 6.8), 10% SDS,'20% glycerol and 1% bromophenol blue) 
and 10 yl of 2-mercaptoethanol. The mixture was placed in boiling water 
for 3 minutes and stored at -20°C. 
Samples were electrophoresed (30 mA constant current for approximately 
3.5 hours) in the presence of SDS, through a discontinuous, 10% poly-
acrylamide gel crosslinked with N, N'-diallyltartardiamide (DATD). Gels 
were dried and autoradiography was performed using Kodak XAR-5 film. 
Molecular weights of viral polypeptides were determined by comparison 
with protein standards of known molecular weights. 
Western Blot 
One ml of CAE (7 mg total protein) was treated with dissolving buffer 
and 2-mercaptoethanol, loaded into a 2.5 X 13 mm well and electrophoresed 
in the presence of SDS as described above. After electrophoresis, the 
gel was given three-10 minute washes in 0.025 M sodium phosphate buffer, 
pH 6.8 (transfer buffer). Electrophoretic blot transfer was performed 
as described previously (6) except that the pH 6.8 transfer buffer was 
used. The nitrocellulose sheet, containing the transferred SDS-PAGE 
pattern was cut into 1 cm strips and treated, with constant shaking, 
as follows: 1) three 15 minute washes in 10 mis of 0.01 M Tris-saline 
buffer, containing 0.05% Tween 20, at pH 8.6 (TS-TW20 buffer), 2) two 
hour incubation with 0.5 ml of globulin in 10 ml of TS-TW20 buffer, 
125 
3) repeat step 1, 4) one hour incubation with 6 yCi I-protein A 
38b 
(6.95 liCi/yg specific activity) in 10 ml of TS-TW20 buffer, 5) repeat 
step 1. Data were analyzed by direct autoradiography at -70°C using 
Kodak XAR-5 film and an intensifying screen. 
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RESULTS 
Serum Neutralization and Immunoprecipitation SDS-PAGE 
Immunoprecipitation SDS-PAGE reference patterns were formed using 
reference antibody and ^ S^-methionine (Figure 1,B) or ^ C^-glucosamine-
(Figure 1,A) labeled CAE. A minimum of 10 polypeptides was detected; 
eight of these were glycosylated. 
Monospecific rabbit globulin, prepared against individual immuno-
precipitates cut from line inmunoelectrophoresis gels, were reacted in 
IP-PAGE with radiolabeled CAE. The IP-PAGE results are summarized in 
Table 1. Three basic polypeptide patterns were found to be associated 
with SN activity. Group A sera (n=4) had a geometric mean SN antibody 
titer (GMT) of ^ 1:45 (range 1:32 to >1:64) and precipitated a major 
glycopeptide with a molecular weight of 77-81K dalton (Figure 1,C and D). 
Group B sera (n=4) had a GMT of 1:6 (range 1:2 to 1:16) and precipitated 
a major glycopeptide with a molecular weight of 82-92K dalton (Figure 1, 
E and F). Group C sera (n=4) had a GMT of 1:6 (range 1:2 to 1:16) and 
precipitated 2 major glycopeptides with molecular weights of 69-75K and 
108-115K dalton (Figure 1,G and H). These majoy glycopeptides appeared 
35 
as four distinct bands when S-methionine-labeled CAE was reacted 
simultaneously with Groups A, B and C sera (not shown) . One of the four 
serum samples in each group (A, B, or C) was selected to form its repre­
sentative pattern in Figure 1. 
Two minor polypeptides, 47K and 49K dalton molecular weights, co-
precipitated along with the major glycopeptides. These polypeptides 
Figure 1 Iiranunoprecipltatlon SDS-PAGE results. Crude antigen extract, labeled with 
^^ C-glucosamine, was used for immunoprecipitation in lanes A, D, F and H. Crude 
35 
antigen extract, labeled with S-methionine, was used for immunoprecipitation in 
lanes B, C, E, G, I and K. Polypeptides in lanes C and D were immunoprecipitated 
by Group A sera. Polypeptides in lanes E and F were immunoprecipitated by Group B 
sera. Group C sera immunoprecipitated polypeptides in lanes G and H. Crude antigen 
35 
extract control, labeled with S-methionine, was used for immunoprecipitation in 
lanes J and L. Rabbit sera, produced against antigens that did not induce SN antibody, 
was used for immunoprecipitation in lanes K and L. Reference antibody was used for 
immunoprecipitation in lanes I and J. 
Western blot results. Reactions of the CAE, SDS-PAGE pattern in Western blot with rabbit 
sera produced against CAE control, reference antibody. Group A, Group B and Group C sera 
are shown in lanes M, N, 0, P and Q, respectively. 
A  B  C D E F  G H  
108-115K 
82-92K 
69-75K 
99-1Q4K 
77-81K 
50-53K-
47K- 49K-
42 
Table 1. Characterization of serum neutralizing monospecific rabbit 
sera by imnunoprecipitation SD5-PAGE 
Molecular Weight^  Group A sera Group B sera Group C sera 
(kilodalton) Glycosylation^  (GMT _> 1:45)C (GMT 1:6) (GMT 1:6) 
131 - _d - -
108-115 + - - + 
99-104 + - - -
82-92 + - + -
77-81 + + - -
69-75 + - + 
66 - - - -
50-53 + - - -
49 + + + + 
47 + + + + 
M^olecular weight values were averaged from patterns in 4 different 
gels. 
 ^Presence (+) or absence (-) of ^ C^-glucosamine in each polypeptide 
band. 
G^eometric mean serum neutralizing antibody titer (GMT)"; n=4. 
 ^Presence (+) or absence (-) of polypeptide bands in patterns 
obtained after reaction of 35s-methionine-labeled CAE with 
Group A, B or C sera. 
43a 
appeared in IP-PAGE patterns formed by reacting reference antibody with 
35 S-methionine-labeled CAE control (Figure 1,J) and in IP-PAGE patterns 
35 formed by reacting S-methionine-labeled CAE with rabbit sera prepared 
against an immunoprecipitate that did not induce SN activity (Figure 1, 
35 
K and L) . Incubation of Group A, B or C sera with S-methionine or 
^^ C-glucosamine-labeled CAE control did not precipitate any polypeptides, 
nor were any precipitated when reference antibody was reacted with 
^^ C-glucosamine-labeled CAE control. Group C sera appeared to precipitate 
a greater quantity of the 47K and 49K dalton molecular weight polypeptides, 
followed by Group A, then Group B sera. 
Western Blot. 
Crude antigen extract SDS-PAGE patterns were transferred electro-
phoretically to nitrocellulose. Incubation of reference antibody with 
the transferred pattern gave results similar to those obtained with 
IP-PAGE, however, the bands responsible for inducing SN antibody were 
ill-defined (Figure 1,N). Reactions of Group A and Group B sera with 
what appeared to be the 77-81K dalton and the 82-92K dalton polypeptides 
(Figure 1,0 and P, respectively) were detected only after prolonged 
film exposure. The 69-75K and the 108-115K dalton polypeptides (pre­
cipitated by Group C sera) were not detected by this method (Figure 1,Q). 
Antibody prepared against CAE control reacted with a polypeptide of 
molecular weight less than 4OK dalton (Figure 1,M). Western blot results 
did not correlate completely with the IP-PAGE data. Differences may 
reflect the ability of IP-PAGE to detect conformational antigenic 
43b 
determinants, while Western blot detects primarily sequential antigenic 
determinants. 
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DISCUSSION 
Four BHV-1 glycopeptides appear to be involved in inducing anti-
BHV-1 SN antibody in the rabbit. The 77-81K dalton glycopeptide induced 
higher SN antibody titers than the 82-92K dalton glycopeptide or the 
two co-precipitating (69-75K and 108-115K dalton) glycopeptides, however, 
differences in titer may be due to differences in antigenic mass. The 
69-75K and the 108-115K dalton glycopeptides may represent 1) subunits 
of a single protein, 2) monomer and dimer forms of a protein (similar 
to herpes simplex virus-1 glycoprotein gB (10)), or 3) mature and 
immature forms of a protein. 
The weak reactions of SN positive sera in Western blot analysis 
suggest a binding preference for conformational determinants. The 77-81K 
and the 82-92K glycopeptides appear to possess linear determinants reactive 
with serum neutralizing antibody. These glycopeptides may be the 
inmunogens of choice for subunit vaccines to be produced by recombinant 
methods. Cloned viral proteins, prepared as bacterial fusion products, 
may lose conformational determinants as a result of improper protein 
folding. 
It was difficult to compare our viral polypeptides with those 
reported previously, since authors of these reports used different poly-
acrylamide gel systems. On the basis of molecular weight, two glyco­
peptides reported by Misra et al. (7), GVP 9 (82K) and GVP 11 (74K) 
appear to correspond, respectively, to the 82-92K and the 69-75K 
glycopeptides reported in this study. Our 77-81K glycopeptide has not 
44b 
been reported previously. It does not appear to correspond to any of 
the glycopeptides in Misra's patterns. This may reflect the ability of 
DATD-linked acrylamide gels to resolve polypeptides species that 
comigrate in bis-linked gels (3). 
Additional studies are needed to characterize the 47K and the 49K 
dalton polypeptides. Our data do not clarify whether they are of host 
or viral origin, or whether they are nonspecific reactants in IP-PAGE. 
They do not appear to play a major role in inducing SN antibody; rabbit 
sera that imnunoprecipitate greater quantities of these polypeptides do 
not demonstrate increased SN antibody titers. 
45 
ACKNOWLEDGEMENTS 
We thank Ms. Sheree Beam and Mr. Tom van der Linden for their 
excellent technical assistance. This work was supported by USDA/SEA 
Special Research Grant no. 59-2191-1-2-072-0. 
46 
REFERENCES 
1. Bolton, D. C., Y. C. Zee, and A. A. Ardans. 1983. Identification 
of envelope and nucelocapsid proteins of infectious bovine 
rhinotracheitis virus by SDS-polyacrylamide gel elctrophoresis. 
Vet. Micro. 8:57-68. 
2. Campbell, D. H., J. S. Garvey, N. E. Cremer, and D. H. Sussdorf. 
1970. Methods in immunology. 2nd ed. W. A. Benjamin, Inc., 
New York. 189 pp. 
3. Heine, J. W., R. W. Honess, E. Cassai, and B. Roizman. 1974. 
Proteins specified by herpes simplex virus. XII. The virion 
polypeptides of type 1 strains. J. Virol. 14:640-651. 
4. Kahrs, B. 1976. Infectious bovine rhinotracheitis. A review and 
update. J. Am. Vet. Med. Assoc. 171:1055-1064. 
5. Kr^ ll, J. 1973. Line immunoelectrophoresis. Scand. J. Immunol. 2 
(Suppl. 1):61-67. 
6. Lum, M. A,, and D. E. Reed. 1983. Electrophoretic protein transfer 
applied to immunoelectrophoresis. J. Immunol. Methods 64:377-382. 
7. Misra, V., R. M. Blumenthal, and L. A. Babiuk. 1981. Proteins 
specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis 
virus). J. Virol. 40:367-378. 
8. Misra, V., J. E. Gilchrest, G. Weinmaster, L. Qualtiere, S. Van den 
Hurk, and L. A. Babiuk. 1982. Herpesvirus-induced "early" 
glycoprotein: Characterization and possible role in immune cytolysis. 
J. Virol. 43:1046-1054. 
9. Reed, D. E., E. J. Bicknell, and R. Bury. 1977. Systemic form 
of infectious bovine rhinotracheitis in young calves. J. Am. 
Vet. Assoc. 163:753-755. 
10. Sarmiento, M., and P. G. Spear. 1979. Membrane proteins specified 
by herpes simplex viruses. IV. Conformation of the virion glyco­
protein designated VP7 (Bg). J. Virol. 29:1159-1167. 
47 
SUMMARY AND CONCLUSIONS 
This study involved the identification and characterization of 
detergent soluble, BHV-1 specified antigens involved in inducing serum 
neutralizing antibody. The nonionic detergent, Nonidet P-40, was used 
to solubilize BHV-1 infected cells. Monospecific sera against individual 
BHV-1 antigens were prepared by preparative line immunoelectrophoresis; 
individual iiranunoprecipitates were used to immunize rabbits. 
A method was devised to test the monospecificity of the rabbit 
sera. A BHV-1 CIE pattern was formed using the crude antigen extract 
and bovine hyperimmune serum. The CIE pattern was transferred electro-
phoretically to a nitrocellulose sheet. Transferred antigen was able to 
125 
react with rabbit sera (detected by I-labeled anti-species antibody); 
autoradiography revealed the antigen arc(s) for which the sera were 
specific. 
Monospecific rabbit sera possessing anti-BHV-1 serum neutralizing 
activity were analyzed by reaction with crude antigen extract in immuno-
precipitation SDS-PAGE and Western blot. Results indicated that a 
77-81K dalton glycopeptide and an 82-92K dalton glycopeptide were involved, 
separately, in inducing serum neutralizing antibody. Two glycosylated 
polypeptides (69-75K and 108-115K dalton) always co-precipitated and 
also appeared to induce serum neutralizing antibody. 
The following conclusions may be made: 
1. The electrophoretic transfer of BHV-1 CIE patterns to nitrocellulose 
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was successful and useful for determining the specificity and 
confirming the purity of monospecific sera. 
Four BHV-1 glycopeptides appear to be involved in inducing anti-
BHV-1 serum neutralizing antibody in the rabbit. 
Further research is needed in the following areas: 
The BHV-1 specified glycoproteins profiled in these immuno-
precipitation SDS-PAGE studies should be isolated and their 
protective activity in cattle evaluated. Results should identify 
the glycoprotein(s) that could be used in an effective subunit 
vaccine. 
Immunologically reactive BHV-1 infected cell glycoproteins should 
be compared to those present in the virion to identify structural 
and nonstructural components. The ability of these glycoproteins 
to participate in antibody-dependent cytolysis of infected cells 
and to induce cellular immunity should be evaluated. 
The isolation of BHV-1 mutants lacking one or more of these 
proteins may provide a basis for understanding the biological 
function of these proteins. 
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